Monopar Therapeutics (MNPR) Shares Outstanding (2016 - 2020)

Monopar Therapeutics' Shares Outstanding history spans 4 years, with the latest figure at $11.5 million for Q3 2020.

  • For Q3 2020, Shares Outstanding rose 23.26% year-over-year to $11.5 million; the TTM value through Sep 2020 reached $11.5 million, up 23.26%, while the annual FY2019 figure was $10.6 million, 13.95% up from the prior year.
  • Shares Outstanding for Q3 2020 was $11.5 million at Monopar Therapeutics, up from $10.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $11.5 million in Q3 2020 and bottomed at $9.3 million in Q4 2017.
  • The 4-year median for Shares Outstanding is $9.3 million (2017), against an average of $9.8 million.
  • The largest annual shift saw Shares Outstanding changed 0.0% in 2018 before it increased 23.26% in 2020.
  • A 4-year view of Shares Outstanding shows it stood at $9.3 million in 2017, then changed by 0.0% to $9.3 million in 2018, then rose by 13.95% to $10.6 million in 2019, then increased by 8.17% to $11.5 million in 2020.
  • Per Business Quant, the three most recent readings for MNPR's Shares Outstanding are $11.5 million (Q3 2020), $10.7 million (Q2 2020), and $10.6 million (Q1 2020).